Delivery Order SPE2DB22D1017-SPE2DB24FF2MG
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,525.82 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, with a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,756.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML autoinjector medication. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract (SPE2DX15D2217|SPE2DX24F66XE) by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML autoinjectors. The $1,354.23 contract has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor for this delivery order, which is part of a larger...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $2,528.28 delivery order has a completion date of March 8, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceuticals and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,520.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The delivery order has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,264.14 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML AUTOINJECTORML. The order, which has a completion date of January 11, 2024, is part of Amerisourcebergen's ongoing support of DLA Troop Support Medical programs to supply pharmaceuticals and medical supplies to military treatment facilities. As a prime contractor, Amerisourcebergen has received...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $7,799.19 order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The $1,914.60 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,901.62 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00, awarded to Amerisourcebergen by the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract (SPE2DX24F05L5) by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $5,383.94 and a period of performance through April 8, 2024. This delivery order is placed under an indefinite delivery contract (SPE2DX15D3504) with a potential value of $999,999,999.00...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF2MGDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $2,578.56 by the Defense Logistics Agency (DLA) for the supply of AIMOVIG 70 MG/ML AUTOINJECTOR. The delivery order has a completion date of February 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have any set-aside designations.
Generated 5/8/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 2/7/24 |